Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC

NCT05228951 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole

Sponsor

Shengjing Hospital